NAT2 and age-related macular degeneration: These results may imply that a genetic predisposition to AMD conferred by the CFH Y402H polymorphism limits the benefits provided by DHA supplementation, and might explain the limited benefit of DHA supplementation for occurrence of CNV in NAT2 or AREDS2 studies.